Synergy Pharmaceuticals to Present at Oppenheimer 27th Annual Healthcare Conference
March 14 2017 - 7:30AM
Business Wire
Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) today announced that
Marino Garcia, the company’s EVP and Chief Strategy Officer, will
present a corporate update at the Oppenheimer 27th Annual
Healthcare Conference on Tuesday, March 21, 2017 at 11:30 a.m.
Eastern Time at The Westin New York Grand Central in New York
City.
A live webcast of the presentation will be accessible through
the Investor Relations section of the company’s website at
www.synergypharma.com. A replay of the webcast will be available on
Synergy’s website for 60 days following the conference.
About Synergy Pharmaceuticals Inc.
Synergy is a biopharmaceutical company focused on the
development and commercialization of novel gastrointestinal (GI)
therapies. The company has pioneered discovery, research and
development efforts on analogs of uroguanylin, a naturally
occurring and endogenous human GI peptide, for the treatment of GI
diseases and disorders. Synergy’s proprietary uroguanylin analog
platform includes one commercial product TRULANCE™ (plecanatide)
and a second lead product candidate, dolcanatide. For more
information, please visit www.synergypharma.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170314005233/en/
Synergy Pharmaceuticals Inc.Gem Hopkins, 212-584-7610VP,
Investor Relations and Corporate
Communicationsghopkins@synergypharma.com
Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP)
Historical Stock Chart
From Apr 2024 to May 2024
Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Synergy Pharmaceuticals, Inc. (NASDAQ): 0 recent articles
More Synergy Pharmaceuticals, Inc. (MM) News Articles